Eupressyl and Epilepsy aggravated - a phase IV clinical study of FDA data

Summary:

Epilepsy aggravated is reported as a side effect among people who take Eupressyl (urapidil), especially for people who are female, 60+ old, also take Movicol, and have High blood pressure.

The phase IV clinical study analyzes which people have Epilepsy aggravated when taking Eupressyl. It is created by eHealthMe based on reports of 2,821 people who have side effects when taking Eupressyl from the FDA, and is updated regularly.

What is Eupressyl?

Eupressyl has active ingredients of urapidil. eHealthMe is studying from 2,825 Eupressyl users. Check the latest studies of Eupressyl.

What is Epilepsy aggravated?

Epilepsy aggravated (serious common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,084 drugs and 457 conditions by eHealthMe. Check the latest studies of Epilepsy aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

2,821 people reported to have side effects when taking Eupressyl.
Among them, 13 people (0.46%) have Epilepsy aggravated.

Could Eupressyl cause Epilepsy aggravated?

Among these 13 people:

What is the gender of people who have Epilepsy aggravated when taking Eupressyl? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Epilepsy aggravated when taking Eupressyl? *

What are other drugs people take besides Eupressyl? *

What are other side effects people have besides Epilepsy aggravated? *

Hypoglycaemic Coma (coma due to deficiency of glucose in the bloodstream): 3 people, 23.08%
Heart Attack: 3 people, 23.08%
Hyperkalemia (damage to or disease of the kidney): 3 people, 23.08%
Hypoglycemia (low blood sugar): 2 people, 15.38%
Chronic Kidney Disease: 1 person, 7.69%
Consciousness - Decreased: 1 person, 7.69%
Dizziness: 1 person, 7.69%
Enterococcus Test Positive: 1 person, 7.69%
Gastric Ulcer Haemorrhage (bleeding ulcer of stomach): 1 person, 7.69%
Gingival Bleeding (bleeding gums): 1 person, 7.69%

What are the existing conditions these people have? *

High Blood Pressure: 10 people, 76.92%
Urinary Tract Infection: 8 people, 61.54%
Constipation: 7 people, 53.85%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 38.46%
Anaemia (lack of blood): 5 people, 38.46%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 5 people, 38.46%
Colitis (inflammation of colon): 5 people, 38.46%
Hyperchlorhydria (gastric acid levels are higher in stomach): 5 people, 38.46%
Lung Disorder (lung disease): 5 people, 38.46%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 5 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Eupressyl and have Epilepsy aggravated?

- Check whether Epilepsy aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eupressyl:

Eupressyl (2,825 reports)

Browse all side effects of Eupressyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epilepsy aggravated:

Epilepsy aggravated (1,084 drugs)

Browse all the conditions that are associated with Epilepsy aggravated:

Epilepsy aggravated (457 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on urapidil (the active ingredients of Eupressyl) and Eupressyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.